|
Insurers are the gatekeepers of health care for
most Americans. This arrangement can put investigational and
experimental medical treatments out of reach. Unless you are wealthy
and can afford to fly to Switzerland for a new life-saving procedure,
there is rarely anyone you can turn to who will foot the bill for an
experimental surgery, even in the most dire of cases.
Health insurers set the criteria for what is
“generally accepted by the medical community.” More often than not, an
insurer will deny a request that falls outside of these criteria. For
the terminally ill, the window of opportunity for life-saving treatment
can close swiftly.
Treatments falling outside the bounds of "generally
accepted" include face transplants, weight loss surgery for children
and new methods to cure diabetes and cancer. (See list below.)
Clinical trials for cancer treatment
|
Twenty states have enacted laws mandating insurance coverage of
clinical trials for cancer victims. For more information about state
clinical trial laws, go to the National Conference of State Legislatures.
|
For some patients with genetic defects and
serious injuries, experimental surgeries could mean the difference
between living a higher quality life to one that is riddled with pain
and disability.
Most everyone would agree that health insurers
shouldn’t be expected to cover every medical treatment invented,
especially when treatments lack a track record of success. But that
leaves scores of effective "experimental" and "investigational"
treatments on the outs.
Mark Hiepler, an attorney in Oxnard, Calif., who specializes in health insurance
denial cases involving last-hope treatments for patients, saw this
injustice first-hand. His first insurance case involved his sister,
Nelene Fox, who suffered from late-stage breast cancer.
Fox
sought approval from her insurer, Health Net Inc., to pay for a
$200,000 bone marrow transplant in an effort to stay alive. The insurer
called the procedure "investigational" and denied it. Her friends and
family then raised funds for the procedure, but it was too late — Fox
died in 1993 at the age of 50. Less than a year later, Hiepler and his
brother-in-law won an $89.3 million verdict against Health Net for its
denial of treatment. Hiepler now devotes a large portion of his
practice to managed care lawsuits and patient rights.
"Most patients are not equipped financially and
emotionally to fight a long battle in court for a procedure that was
denied by the insurance company, on top of their deteriorating
condition," says Hiepler. "Even if the initial surgery was approved,
they may be fighting another disease or an infection and cannot afford
further treatment. Having to come up with another $100,000 is
impossible for them, so when they are denied, they don't fight the
insurer."
In the case of his sister, Hiepler learned during
his court battle that the insurance representative who denied her
surgery received incentives for holding costs down — including denying
claims.
Hiepler says that when it comes to health insurance denials, the crux of the matter is what "experimental" means in the eyes of the insurer.
"The definition that an insurer uses is very
different from the definition a doctor might use. For the insurance
company, it usually means the procedure is too expensive. All medicine
by its very nature is experimental because the medical profession is
always trying to improve on it," he says. "When you try to decipher the
insurance company's definition against the definition of the procedure,
it never fits. Insurers have gone to great lengths to broaden the
definition [of experimental] so they can create a black hole, and no
one can fit under their definition."
Especially infuriating to patients is the knowledge
that some of these procedures are widely available and accepted
overseas. We went out looking for some of the medical treatments that
will likely be denied by health insurers but can be obtained by those
with big enough bank accounts or by patients who travel overseas.
This addresses face disfigurement due to birth
defects, burns, accidents and animal attacks. It is an experimental
procedure where the patient's face is removed and replaced (including
fat, nerves and blood vessels, but no facial muscles) with the face of
a cadaver. The procedure is risky and has raised several ethics issues
in the medical community. Patients will have to endure a lifelong
regimen of immunosuppressive drugs to suppress their own immune system
from rejecting the new face tissue. Immunosuppression increases the
risk of developing kidney damage, cancer and severe infections.
This is still in experimental stages. To date, only
Australia, China, France, India, the United Kingdom, and Cleveland
Clinic in the U.S. have carried out surgeries on patients.
|
|
Duodenal-jejunal bypass surgery or Modified Duodenal Switch Procedure:
This surgery is for Type II diabetes and blocks food from traveling
through the duodenum (the top of the small intestine). The surgery has
been successful in sending diabetes into extended remission. It is in
U.S. clinical trials and some insurers may cover this procedure.
|
Intraocular lens implant (implantable lenses): This
is used to prevent progressive blindness in children and involves
implanting permanent contact lenses directly into the eye. This is in
U.S. clinical trials.
|
|
This is a last-ditch effort to stop the pain of
severe chronic migraines. A tiny electrode is attached to a needle and
placed under the skin and on top of the nerve responsible for migraine
pain. The device continually zaps the nerve with electric pulses that
block pain. Using electrodes to block migraine pain is still
experimental and the implant costs between $5,000 and $10,000. This is
not covered by most insurers and is available in Spain.
|
Gamma knife capsulotomy (gamma knife radio surgery, thermocapsulotomy): This
is a helmet-like device through which patients receive highly focused
beams of heat that destroy tumors and brain abnormalities but spare
healthy brain tissue. This procedure is still in investigational trials
for Obsessive-Compulsive Disorder (OCD) by the National Institutes of
Health and is not covered by insurance.
|
|
Transcranial magnetic stimulation (TMS): Magnetic
pulses are focused on the brain's supplementary motor area (SMA), a
part of the brain that controls motor functions. The SMA plays a role
in filtering out problems such as ruminations, obsessions and tics. TMS
attempts to normalize the brain's motor activity so that it properly
filters out thoughts and behaviors associated with OCD or severe
depression. Approved by the FDA, it is still in investigational trials.
|
|
Olfactory mucosa transplantation: This
surgery for spinal cord injuries involves removing cells from the nerve
that transmits the sense of smell to the brain. These brain cells,
found near the nasal cavity, regenerate efficiently and are then
transplanted into the injured area of the spinal cord. The transplanted
cells then transform into nerve cells that help repair the spinal cord
injury. This is not approved by the FDA and treatment can be obtained
only in Portugal.
|
Gender reassignment:
This procedure changes genital organs from one gender to another. This
surgery is rarely covered by insurers, but it is covered by Medicaid in
Washington. The cost for male-to-female reassignment is $7,000 to
$24,000, while the cost for female-to-male reassignment can exceed
$50,000.
|
|
Natural orifice transluminal endoscopic surgery:
Noninvasive organ removal that is performed by passing an endoscope
through the mouth, urethra or anus. The surgery is virtually scarless.
It's not approved by the FDA and not covered by insurers. This surgery
is being conducted in Brazil and India.
|
|
Lap band surgery for minor:
This treats severe obesity in children. The surgeon places an
adjustable silastic band around the upper part of the stomach to create
a new small pouch above the band. The tightness of the banded opening
controls the passage of food between the two sections of the stomach
and helps patients feel full after eating. The surgery has been
approved for adults in the U.S. but not children. For minors, this is
available in Mexico and South/Central America.
|
Treats a crushed spinal cord, cancer, Type I
diabetes or muscle damage. It uses embryonic stem cells or master cells
that can be harvested and transformed into specialized cells that make
up tissues such as muscles, nerves, organs and bones. Stem cells
contribute to the body's ability to renew and repair its tissues. This
surgery is being conducted in China, Denmark, Iceland, India, Italy,
Korea, Portugal, Spain and the United Kingdom.
|
|
Autologous bone marrow transplant:
For breast and ovarian cancer, Hodgkin's disease, non-Hodgkin's
lymphoma and brain tumors. This is when a patient receives a bone
marrow transplant with stem cells from their own bone marrow or blood.
The bone marrow is extracted from the patient and may be "purged" or
"zapped" with high doses of chemotherapy and/or radiotherapy to remove
malignant cells (if the disease has afflicted the bone marrow). The
healthy bone marrow is then transplanted back into the patient.
Breast cancer patients can expect to pay $80,000 for this procedure.
With non-Hodgkin's lymphoma, there is 50 percent
probability of a disease-free survival rate just over three years after
the transplant, according to the Kaplan-Meier survival analysis, which
provides survival information. This is a high-risk, expensive ($100,000
to $200,000 price tag) procedure that is often not covered by insurers.
|
If you've been told your treatment isn't covered
because it's investigational or experimental, you may still have
recourse. Here are steps for getting your insurer to pay for your
treatment.
1. Talk to your doctor about the treatment. Make sure there is not a
treatment that is equal or better to your experimental treatment. "Is
there a more conventional means for successfully treating your disease?
If there is, that may be the better route to go," says Hiepler.
2. Read the provisions in your insurance contract. Ask the insurance
company what other treatments they are most frequently denying as
experimental.
3. Ask the insurer to explain what is experimental about this
procedure. Keep a record of their response. "Most people think the
insurance company is looking out for them, so they look to them as
almost an authority on what is the best treatment for them. Don't fall
into this trap," says Hiepler. "As a rule of thumb, you must challenge
authority at every corner. This is especially important when it's an
insurer you're dealing with."
4. All health plans have an appeals process that you should follow.
Your health insurer will give you information on how to initiate a
formal appeal. If you're not satisfied with that, you can initiate an
external appeals process. For more, read the Kaiser Family Foundation's
Consumer Guide to Handling Disputes with Your Private or Employer Health Plan.
5. Write the CEO of the insurance company and tell them who you are,
that your doctor recommended this treatment, that it's medically
necessary for your survival, that they have a limited amount of time to
approve the procedure, and they have exactly 24 hours to give you an
answer. "Force them to make the decision," Hiepler says.
6. If you haven't gotten an answer, or you haven't gotten an adequate
reason for the denial, the last resort is to find a lawyer who
specializes in insurance denials to take on your case.
The first thing they will ask you is if this is an ERISA or non-ERISA case.
"The Employee Retirement Income Security Act (ERISA) limits claims
against health insurers to federal court, while also preventing
recovery for pain and suffering or punitive damages. Those who buy
their own insurance or receive it from church groups or the government
are exempted," he explains. "If you are exempt from ERISA, you have the
potential to sue the insurance company for something other than the
contract. You can sue them for the hassle and you have a shot at
punitive damages by proving that the insurer showed a conscious
disregard for the rights and safety of a patient."
7. When speaking to an insurer, watch your language. "Do not under any
circumstances refer to your surgery as 'experimental' or
'investigational' during the course of your conversation. They are
looking for cues to figure out a way not to cover the procedure and
language and how the procedure is defined is everything," advises
Hiepler.
Hiepler adds that if your case goes to trial, you
have a shot at winning the case if you can prove the original contract
was filled with ambiguous language regarding the exclusions of the
contract.
"If the denial process is ambiguous and the
language in the contract is unintelligible, the insured wins. If there
is clear language that specifically excludes the procedure or
treatment, the insurer might win," he says. |